Skip to content

The Emergency Department Sedation Pilot Trial

The ED-SED Pilot: a Multicenter, Before-After Study to Improve Sedation in the Emergency Department

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04410783
Acronym
ED SED Pilot
Enrollment
1771
Registered
2020-06-01
Start date
2020-09-14
Completion date
2022-05-28
Last updated
2022-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mechanical Ventilation, Respiratory Failure

Keywords

Sedation, Mechanical Ventilation, Emergency Department, RASS

Brief summary

The ED-SED Pilot is a multicenter, prospective, before-and-after study conducted on 344 mechanically ventilated emergency department patients at three academic medical centers: Washington University in St. Louis School of Medicine (St. Louis, MO), Cooper Hospital of Rowan University (Camden, NJ), and University of Iowa Carver College of Medicine (Iowa City, IA). The overall goal is to assess the feasibility of implementing targeted sedation (in terms of sedation depth) for mechanically ventilated ED patients in order to reduce the incidence of unnecessary deep sedation and improve clinical outcomes.

Detailed description

The ED-SED Pilot is a multicenter, prospective, before-and-after study conducted on 344 mechanically ventilated ED patients at three academic medical centers. Patients in the before phase of the study will receive usual care after the initiation of mechanical ventilation. After 172 patients have been enrolled in the before phase, the investigators will begin educational initiatives to implement ED-based sedation protocols and order sets. The research team will educate providers on the importance of sedation protocols on patient outcome so that the existing protocols begin to be used effectively in the ED. This educational initiative will allow targeted sedation to be effectively used in the ED as well, allowing the intervention to be tested under real-world conditions. Participants in the after phase will also receive standard post-intubation care at the discretion of the treating team, though it will be after the educational initiative aimed at improving post-intubation sedation. In order to more effectively use sedation in the ED, the investigators will collect voluntary and anonymous surveys from ED nurses and physicians to assess the potential facilitators and barriers to adherence to guideline-recommended sedation.

Interventions

BEHAVIORALEducation

Nurses and physicians will be engaged regarding the clinical outcome data on the importance of ED-based sedation, and the objectives of the research. Education will include in-services and lectures focused on the importance of sedation protocols on patient outcome. The use of sedation will be evaluated throughout the study in order to better understand providers' perception of and experience with ED-based sedation protocols.

OTHERStandard post intubation sedation practices

Usual care sedation provide in the ED

Sponsors

University of Iowa
CollaboratorOTHER
Cooper University Health Care
CollaboratorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

This is a prospective, before-and-after study, and there will be no randomization process.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Mechanical ventilation via an endotracheal tube. 2. Age ≥ 18 years.

Exclusion criteria

1. Acute neurologic injury (stroke, intracranial hemorrhage, traumatic brain injury, cardiac arrest, status epilepticus, fulminant hepatic failure). 2. Ongoing neuromuscular blockade. 3. Death or transition to comfort measures within 24 hours. 4. Transfer to another hospital from the ED. 5. Chronic/home mechanical ventilation. 6. Transfer directly from the ED to the operating room.

Design outcomes

Primary

MeasureTime frameDescription
Participant RecruitmentThrough study completion, an average of 1 yearCount of eligible participants included in study
Percentage of Patients With Richmond Agitation-Sedation Scale (RASS) Scores in Deep Sedation RangeUp to 12 hours (during mechanical ventilation in the emergency department)Deep sedation defined as RASS of -3 to -5 Measure of Sedation via RASS. Scale: +4 Combative, +3 Very agitated, +2 Agitated, +1 Restless, 0 Alert and Calm, -1 Drowsy, -2 Light sedation, -3 Moderate sedation, -4 Deep sedation, -5 Unarousable
Reliability of Richmond Agitation-Sedation Scale (RASS) Measurements During Routine Care in the EDUp to 12 hours (during mechanical ventilation in the emergency department)Interrater correlation coeficient. These were paired observations between study team members and ED nurses. It reflects the degree of agreement between independent observers.
Number of Participants With Adverse EventsUp to 12 hours (during mechanical ventilation in the emergency department)Inadvertent extubation, inadvertent device removal (e.g. central venous catheter, urinary catheter), awareness with paralysis events

Secondary

MeasureTime frameDescription
Ventilator-free DaysUp to 28 daysTo define, ventilator-free days equal: 1) 0 if patient dies within 28 days of mechanical ventilation; 2) 28 - x if successfully liberated from mechanical ventilation 'x' days after intubation; or 3) 0 if mechanical ventilation duration exceeds 28 days.
MortalityUp to 28 days, or for the duration of hospitalizationHospital mortality
ICU-free DaysUp to 28 daysTo define, ICU-free days equal: 1) 0 if patient dies within 28 days of ICU admission; 2) 28 - x if successfully discharged from the ICU 'x' days after admission to the ICU; or 3) 0 if ICU length of stay exceeds 28 days.
Hospital-free DaysUp to 28 daysTo define, hospital-free days equal: 1) 0 if patient dies within 28 days of hospital admission; 2) 28 - x if successfully discharged from the hospital 'x' days after admission to the hospital; or 3) 0 if hospital length of stay exceeds 28 days.
Number of Participants With DeliriumUp to 7 daysDelirium defined as being CAM-ICU positive as documented by bedside nurse during routine care.

Countries

United States

Participant flow

Participants by arm

ArmCount
Before Group
Mechanically ventilated emergency department patients receiving standard post-intubation sedation prior to an educational initiative on the importance of ED-based targeted sedation Standard post intubation sedation practices: Usual care sedation provide in the ED
196
After Group
Mechanically ventilated emergency department patients receiving post-intubation sedation after an educational initiative aimed at improving sedation practices in the ED Education: Nurses and physicians will be engaged regarding the clinical outcome data on the importance of ED-based sedation, and the objectives of the research. Education will include in-services and lectures focused on the importance of sedation protocols on patient outcome. The use of sedation will be evaluated throughout the study in order to better understand providers' perception of and experience with ED-based sedation protocols.
219
Total415

Baseline characteristics

CharacteristicBefore GroupAfter GroupTotal
Age, Categorical
<=18 years
2 Participants1 Participants3 Participants
Age, Categorical
>=65 years
74 Participants84 Participants158 Participants
Age, Categorical
Between 18 and 65 years
120 Participants134 Participants254 Participants
Age, Continuous57.9 years
STANDARD_DEVIATION 18.4
57.4 years
STANDARD_DEVIATION 18.3
57.6 years
STANDARD_DEVIATION 18.3
Race/Ethnicity, Customized
Race
Asian
6 Participants4 Participants10 Participants
Race/Ethnicity, Customized
Race
Black
71 Participants94 Participants165 Participants
Race/Ethnicity, Customized
Race
Hispanic
14 Participants18 Participants32 Participants
Race/Ethnicity, Customized
Race
Other
4 Participants1 Participants5 Participants
Race/Ethnicity, Customized
Race
White
101 Participants102 Participants203 Participants
Region of Enrollment
United States
196 participants219 participants415 participants
Sex: Female, Male
Female
71 Participants90 Participants161 Participants
Sex: Female, Male
Male
125 Participants129 Participants254 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
40 / 19622 / 219
other
Total, other adverse events
0 / 1960 / 219
serious
Total, serious adverse events
8 / 19611 / 219

Outcome results

Primary

Number of Participants With Adverse Events

Inadvertent extubation, inadvertent device removal (e.g. central venous catheter, urinary catheter), awareness with paralysis events

Time frame: Up to 12 hours (during mechanical ventilation in the emergency department)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Before GroupNumber of Participants With Adverse Events8 Participants
After GroupNumber of Participants With Adverse Events11 Participants
Primary

Participant Recruitment

Count of eligible participants included in study

Time frame: Through study completion, an average of 1 year

Population: These numbers reflect the number of eligible participants who were included in the study for analysis (i.e. the final study population). As mentioned above in Participant Flow, there were 1771 participants assessed for eligibility and 1356 were not eligible for the study. Therefore, the overall number of participants analyzed (i.e. 415) relects this.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Before GroupParticipant Recruitment196 Participants
After GroupParticipant Recruitment219 Participants
Primary

Percentage of Patients With Richmond Agitation-Sedation Scale (RASS) Scores in Deep Sedation Range

Deep sedation defined as RASS of -3 to -5 Measure of Sedation via RASS. Scale: +4 Combative, +3 Very agitated, +2 Agitated, +1 Restless, 0 Alert and Calm, -1 Drowsy, -2 Light sedation, -3 Moderate sedation, -4 Deep sedation, -5 Unarousable

Time frame: Up to 12 hours (during mechanical ventilation in the emergency department)

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Before GroupPercentage of Patients With Richmond Agitation-Sedation Scale (RASS) Scores in Deep Sedation Range118 Participants
After GroupPercentage of Patients With Richmond Agitation-Sedation Scale (RASS) Scores in Deep Sedation Range85 Participants
Primary

Reliability of Richmond Agitation-Sedation Scale (RASS) Measurements During Routine Care in the ED

Interrater correlation coeficient. These were paired observations between study team members and ED nurses. It reflects the degree of agreement between independent observers.

Time frame: Up to 12 hours (during mechanical ventilation in the emergency department)

Population: Reliability of RASS assessments was only assessed in the after group as an assurance that the protocol was being effectively implemented and RASS measured appropriately

ArmMeasureValue (NUMBER)
After GroupReliability of Richmond Agitation-Sedation Scale (RASS) Measurements During Routine Care in the ED0.88 ICC
Secondary

Hospital-free Days

To define, hospital-free days equal: 1) 0 if patient dies within 28 days of hospital admission; 2) 28 - x if successfully discharged from the hospital 'x' days after admission to the hospital; or 3) 0 if hospital length of stay exceeds 28 days.

Time frame: Up to 28 days

ArmMeasureValue (MEAN)Dispersion
Before GroupHospital-free Days14.3 daysStandard Deviation 10.1
After GroupHospital-free Days15.2 daysStandard Deviation 9.2
Secondary

ICU-free Days

To define, ICU-free days equal: 1) 0 if patient dies within 28 days of ICU admission; 2) 28 - x if successfully discharged from the ICU 'x' days after admission to the ICU; or 3) 0 if ICU length of stay exceeds 28 days.

Time frame: Up to 28 days

ArmMeasureValue (MEAN)Dispersion
Before GroupICU-free Days18.1 daysStandard Deviation 10.4
After GroupICU-free Days20.8 daysStandard Deviation 8.7
Secondary

Mortality

Hospital mortality

Time frame: Up to 28 days, or for the duration of hospitalization

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Before GroupMortality40 Participants
After GroupMortality22 Participants
Secondary

Number of Participants With Delirium

Delirium defined as being CAM-ICU positive as documented by bedside nurse during routine care.

Time frame: Up to 7 days

Population: We recognize that the Overall Number of Participants Analyzed is not consistent with numbers provided in any of the rows in the Participant Flow module. The numbers analyzed for delirium reflect the fact that some patients either died or were discharged and therefore not eligible to be assessed for delirium during the time frame.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Before GroupNumber of Participants With Delirium63 Participants
After GroupNumber of Participants With Delirium62 Participants
Secondary

Ventilator-free Days

To define, ventilator-free days equal: 1) 0 if patient dies within 28 days of mechanical ventilation; 2) 28 - x if successfully liberated from mechanical ventilation 'x' days after intubation; or 3) 0 if mechanical ventilation duration exceeds 28 days.

Time frame: Up to 28 days

ArmMeasureValue (MEAN)Dispersion
Before GroupVentilator-free Days19.9 daysStandard Deviation 10.6
After GroupVentilator-free Days22.0 daysStandard Deviation 9

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026